Over the last decade, organ preservation has gone from hardware store coolers filled with ice to high-tech preservation systems that have been shown to significantly increase organ viability and patient
The Human Behind the Machine: Why Healthcare Must Resist the Rush To Automate
In February, Waymo’s chief safety officer testified before the U.S. Senate that remote operators in the Philippines help guide its supposedly autonomous vehicles. The headline was about outsourcing. The real
FDA Reversal on uniQure Gene Therapy Is Another Sign of Renewed Regulatory Flexibility
The FDA now agrees uniQure’s clinical data for its Huntington’s disease gene therapy can support a regulatory submission in this rare neurodegenerative disorder, reversing its stance just a few months
AI Won’t Fix Physician Burnout — Giving Them More Autonomy Will
The healthcare industry has made its decision: AI is the answer to physician burnout. Ambient scribes, automated documentation, clinical co-pilots, the investment is real and the early data on reducing
Beyond the Pilot Trap: How Healthcare Can Scale AI Without Losing Trust
The question facing healthcare leaders today is no longer whether Artificial Intelligence (AI) will be transformative, but whether our organizations can transform quickly enough to harness it at an enterprise
Researchers Say Whole-Body MRI Companies Are Inflating the Scans’ Medical Benefits
A growing number of Americans are paying thousands of dollars out of pocket for elective whole-body MRI scans, drawn by the promise of catching fatal diseases early. The companies offering
Kardigan’s IPO Lands $400M for Drugs That Get to Root Causes of Heart Diseases
Cardiovascular disease drugs continue to rank among the most prescribed medicines, but there’s still leave plenty of unmet medical need. Many of these products are one-size-fits all and they manage
Lantern, Marathon Health Launch Partnership to Provide Integrated Primary and Specialty Care
Specialty care company Lantern and primary care provider Marathon Health introduced a new partnership on Thursday that aims to bring down specialty care spend for employers. Dallas, Texas-based Lantern directs
What Life Sciences Companies Get Wrong When Building Cross-Border R&D Structures
Cross-border structures in life sciences are no longer the exception; they are the rule. Whether it’s an Israeli biotech starting up a U.S. subsidiary to tap into the talent pipeline
What Is AI Getting Right — and Wrong — in Healthcare’s Revenue Cycle?
Two to three years ago, investors were telling startups that clinical coding would be fully automated by LLMs within a year — which didn’t quite turn out to be true.









